Androgen Receptor CAG Repeat Length Is Not Associated With the Risk of Incident Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

Prostate - United States
doi 10.1002/pros.21092
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Wiley

Related search

Androgen Receptor Isoforms Expression in Benign Prostatic Hyperplasia and Primary Prostate Cancer

PLoS ONE
Multidisciplinary
2018English

Cag Repeat Number in the Androgen Receptor Gene and Prostate Cancer

Balkan Journal of Medical Genetics
Genetics
2012English

Androgen Receptor CAG Repeat Length Contraction in Diseased and Non-Diseased Prostatic Tissues

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2007English

Modification of BRCA1-Associated Breast Cancer Risk by the Polymorphic Androgen-Receptor CAG Repeat

American Journal of Human Genetics
Genetics
1999English

Transforming Growth Factor Β-Receptor II Protein Expression in Benign Prostatic Hyperplasia Is Associated With Prostate Volume and Inflammation

BJU International
Urology
2010English

A Microbial Contamination of Prostatic Tissue in Benign Prostatic Hyperplasia and Prostate Cancer

Herald Urology
2013English

The Expression of Androgen-Responsive Genes Is Up-Regulated in the Epithelia of Benign Prostatic Hyperplasia

Prostate
OncologyUrology
2009English

Saw Palmetto Extract Is Not Effective for Benign Prostatic Hyperplasia

BMJ
2006English

Qianliening Capsule Treats Benign Prostatic Hyperplasia Through Regulating the Expression of Sex Hormones, Estrogen Receptor and Androgen Receptor

African Journal of Pharmacy and Pharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy